The Rosen Law Firm Reminds Repros Therapeutics, Inc. Shareholders of Important Securities Class Action Deadline -- RPRX


NEW YORK, Aug. 30, 2009 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds investors of the important October 6, 2009 Lead Plaintiff deadline in the class action lawsuit on behalf of all purchasers of Repros Therapeutics, Inc. ("Repros") (Nasdaq:RPRX) common stock from July 1, 2009 through August 3, 2009 (the "Class Period").

To join the Repros class action, go to the website at http://www.rosenlegal.com or call Laurence Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com or pkim@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER. YOU MAY ALSO RETAIN COUNSEL OF YOUR CHOICE.

The complaint charges Repros and certain of its officers with violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint alleges that defendants made misleading statements concerning the adverse events that patients suffered in clinical trials for the Company's lead drug candidate Proellex. The complaint alleges that when the Company disclosed the truth concerning the seriousness of the adverse events, its stock price dropped, damaging investors.

A class action lawsuit has already been filed on behalf of Repros shareholders. If you wish to serve as lead plaintiff, you must move the Court no later than October 6, 2009. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact plaintiff's counsel, Laurence Rosen, Esq. or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at lrosen@rosenlegal.com or pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the world, focusing its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.



            

Contact Data